Skip to content

Data Collection for Next Generation Ultrasound Technology Development

Data Collection for Next Generation Ultrasound Technology Development

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02946229
Enrollment
142
Registered
2016-10-27
Start date
2016-10-26
Completion date
2016-12-06
Last updated
2018-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endstage Renal Disease

Brief summary

The study is designed to collect data from a ultrasound device being used to evaluate feasibility of next generation algorithms for ultrasound data processing and does not test any health outcome.

Detailed description

The study is designed to collect data from a ultrasound device being used to evaluate feasibility of next generation algorithms for ultrasound data processing and does not test any health outcome. All eligible adults (aged 18 or older) will contribute case data from a convenience sample of maintenance hemodialysis population available at the study site and consistent with feasibility assessment of the technology. A relatively large feasibility population is used due to the need to test feasibility of multiple features across variations within this population.

Interventions

DEVICEUltrasound scan

Collection of ultrasound data sets that include routine ultrasound data (eg, extravascular lung fluid, cardiac velocity time integral and inferior vena cava) on the commercial GE Vivid S70 Ultrasound System which are used to test feasibility of next generation ultrasound algorithms being developed to process these data types.

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Intervention model description

The study is designed to collect data from a ultrasound device being used to evaluate feasibility of next generation algorithms for ultrasound data processing and does not test any health outcome. All eligible adults (aged 18 or older) will contribute case data from a convenience sample of maintenance hemodialysis population available at the study site and consistent with feasibility assessment of the technology. A relatively large feasibility population is used due to the need to test feasibility of multiple features across variations within this population.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Are adults (aged 18 years of age or older) at the time of consent; 2. Are undergoing maintenance hemodialysis (MHD); AND 3. Are able and willing to provide written informed consent for participation

Exclusion criteria

1. Have anatomical characteristics or comorbid medical conditions that prevent completion of ultrasound scanning using the study device; OR 2. Are potentially put at additional risk by participating, in the opinion of the investigator.

Design outcomes

Primary

MeasureTime frameDescription
Number of Diagnostic Ultrasound Exams1 dayCollection (number) of ultrasound images representative of sonographic findings routinely observed in the general imaging population.

Countries

United States

Participant flow

Participants by arm

ArmCount
MHD Population Ultrasound
Eligible subjects in a convenience population at the site (Maintenance Hemodialysis, MHD) incidentally undergoingnon-invasive cardiac, pulmonary, and abdominal ultrasound scanning on the commercially available GE Vivid S70 system for use in testing feasibility of new algorithms for processing this data. Ultrasound scan: Collection of ultrasound data sets that include routine ultrasound data (eg, extravascular lung fluid, cardiac velocity time integral and inferior vena cava) on the commercial GE Vivid S70 Ultrasound System which are used to test feasibility of next generation ultrasound algorithms being developed to process these data types.
142
Total142

Baseline characteristics

CharacteristicMHD Population Ultrasound
Age, Customized
>=18 years
142 Participants
Sex/Gender, Customized
Male or Female
142 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 142
other
Total, other adverse events
0 / 142
serious
Total, serious adverse events
0 / 142

Outcome results

Primary

Number of Diagnostic Ultrasound Exams

Collection (number) of ultrasound images representative of sonographic findings routinely observed in the general imaging population.

Time frame: 1 day

Population: No performance or efficacy data were studied; No statistical analysis was performed per the protocol.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
MHD Population UltrasoundNumber of Diagnostic Ultrasound Exams142 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026